United States 3D Printed Drugs Market Report & Forecast 2021-2027

SKU ID : QYR- 19216820

No. of pages : 94

Publishing Date : 23-Sep-2021

Detailed TOC of United States 3D Printed Drugs Market Report & Forecast 2021-2027

1 Introduction to Research & Analysis Reports
1.1 3D Printed Drugs Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States 3D Printed Drugs Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year

2 United States 3D Printed Drugs Overall Market Size
2.1 United States 3D Printed Drugs Market Size: 2021 VS 2027
2.2 United States 3D Printed Drugs Revenue, Prospects & Forecasts: 2016-2027
2.3 United States 3D Printed Drugs Sales: 2016-2027

3 Company Landscape
3.1 Top 3D Printed Drugs Players in United States Market
3.2 Top United States 3D Printed Drugs Companies Ranked by Revenue
3.3 United States 3D Printed Drugs Revenue by Companies
3.4 United States 3D Printed Drugs Sales by Companies
3.5 United States 3D Printed Drugs Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 3D Printed Drugs Companies in United States Market, by Revenue in 2020
3.7 Manufacturers 3D Printed Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 3D Printed Drugs Players in United States Market
3.8.1 List of Tier 1 3D Printed Drugs Companies in United States
3.8.2 List of Tier 2 and Tier 3 3D Printed Drugs Companies in United States

4 Sights by Type
4.1 Overview
4.1.1 By Type - United States 3D Printed Drugs Market Size Markets, 2021 & 2027
4.1.2 Spritam
4.1.3 Others
4.2 By Type - United States 3D Printed Drugs Revenue & Forecasts
4.2.1 By Type - United States 3D Printed Drugs Revenue, 2016-2021
4.2.2 By Type - United States 3D Printed Drugs Revenue, 2022-2027
4.2.3 By Type - United States 3D Printed Drugs Revenue Market Share, 2016-2027
4.3 By Type - United States 3D Printed Drugs Sales & Forecasts
4.3.1 By Type - United States 3D Printed Drugs Sales, 2016-2021
4.3.2 By Type - United States 3D Printed Drugs Sales, 2022-2027
4.3.3 By Type - United States 3D Printed Drugs Sales Market Share, 2016-2027
4.4 By Type - United States 3D Printed Drugs Price (Manufacturers Selling Prices), 2016-2027

5 Sights by Application
5.1 Overview
5.1.1 By Application - United States 3D Printed Drugs Market Size, 2021 & 2027
5.1.2 Children
5.1.3 Elderly
5.1.4 Others
5.2 By Application - United States 3D Printed Drugs Revenue & Forecasts
5.2.1 By Application - United States 3D Printed Drugs Revenue, 2016-2021
5.2.2 By Application - United States 3D Printed Drugs Revenue, 2022-2027
5.2.3 By Application - United States 3D Printed Drugs Revenue Market Share, 2016-2027
5.3 By Application - United States 3D Printed Drugs Sales & Forecasts
5.3.1 By Application - United States 3D Printed Drugs Sales, 2016-2021
5.3.2 By Application - United States 3D Printed Drugs Sales, 2022-2027
5.3.3 By Application - United States 3D Printed Drugs Sales Market Share, 2016-2027
5.4 By Application - United States 3D Printed Drugs Price (Manufacturers Selling Prices), 2016-2027

6 Manufacturers & Brands Profiles
6.1 Aprecia Pharmaceuticals
6.1.1 Aprecia Pharmaceuticals Corporation Information
6.1.2 Aprecia Pharmaceuticals Overview
6.1.3 Aprecia Pharmaceuticals 3D Printed Drugs Sales and Revenue in United States Market (2016-2021)
6.1.4 Aprecia Pharmaceuticals 3D Printed Drugs Product Description
6.1.5 Aprecia Pharmaceuticals Recent Developments
6.2 GlaxoSmithKline
6.2.1 GlaxoSmithKline Corporation Information
6.2.2 GlaxoSmithKline Overview
6.2.3 GlaxoSmithKline 3D Printed Drugs Sales and Revenue in United States Market (2016-2021)
6.2.4 GlaxoSmithKline 3D Printed Drugs Product Description
6.2.5 GlaxoSmithKline Recent Developments
6.3 Revolution Medicines
6.3.1 Revolution Medicines Corporation Information
6.3.2 Revolution Medicines Overview
6.3.3 Revolution Medicines 3D Printed Drugs Sales and Revenue in United States Market (2016-2021)
6.3.4 Revolution Medicines 3D Printed Drugs Product Description
6.3.5 Revolution Medicines Recent Developments
6.4 FabRX
6.4.1 FabRX Corporation Information
6.4.2 FabRX Overview
6.4.3 FabRX 3D Printed Drugs Sales and Revenue in United States Market (2016-2021)
6.4.4 FabRX 3D Printed Drugs Product Description
6.4.5 FabRX Recent Developments

7 United States 3D Printed Drugs Production Capacity, Analysis
7.1 United States 3D Printed Drugs Production Capacity, 2016-2027
7.2 3D Printed Drugs Production Capacity of Key Manufacturers in United States Market

8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints

9 3D Printed Drugs Supply Chain Analysis
9.1 3D Printed Drugs Industry Value Chain
9.2 3D Printed Drugs Upstream Market
9.3 3D Printed Drugs Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 3D Printed Drugs Distributors and Sales Agents in United States Market

10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer

List of Figures, Tables and Charts Available in United States 3D Printed Drugs Market Report & Forecast 2021-2027

List of Tables
Table 1. Key Players of 3D Printed Drugs in United States Market
Table 2. Top 3D Printed Drugs Players in United States Market, Ranking by Revenue (2019)
Table 3. United States 3D Printed Drugs Revenue by Companies, (US$, Mn), 2016-2021
Table 4. United States 3D Printed Drugs Revenue Share by Companies, 2016-2021
Table 5. United States 3D Printed Drugs Sales by Companies, (K Units), 2016-2021
Table 6. United States 3D Printed Drugs Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers 3D Printed Drugs Price (2016-2021) & (USD/Unit)
Table 8. Manufacturers 3D Printed Drugs Product Type
Table 9. List of Tier 1 3D Printed Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 3D Printed Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. Major Manufacturers of Spritam
Table 12. Major Manufacturers of Others
Table 13. By Type – United States 3D Printed Drugs Revenue, (US$, Mn), 2021 & 2027
Table 14. By Type - United States 3D Printed Drugs Revenue (US$, Mn), 2016-2021
Table 15. By Type - United States 3D Printed Drugs Revenue (US$, Mn), 2022-2027
Table 16. By Type - United States 3D Printed Drugs Sales (K Units), 2016-2021
Table 17. By Type - United States 3D Printed Drugs Sales (K Units), 2022-2027
Table 18. By Application – United States 3D Printed Drugs Revenue, (US$, Mn), 2021 VS 2027
Table 19. By Application - United States 3D Printed Drugs Revenue (US$, Mn), 2016-2021
Table 20. By Application - United States 3D Printed Drugs Revenue (US$, Mn), 2022-2027
Table 21. By Application - United States 3D Printed Drugs Sales (K Units), 2016-2021
Table 22. By Application - United States 3D Printed Drugs Sales (K Units), 2022-2027
Table 23. Aprecia Pharmaceuticals Corporation Information
Table 24. Aprecia Pharmaceuticals Description and Major Businesses
Table 25. Aprecia Pharmaceuticals 3D Printed Drugs Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 26. Aprecia Pharmaceuticals 3D Printed Drugs Product
Table 27. Aprecia Pharmaceuticals Recent Developments
Table 28. GlaxoSmithKline Corporation Information
Table 29. GlaxoSmithKline Description and Major Businesses
Table 30. GlaxoSmithKline 3D Printed Drugs Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 31. GlaxoSmithKline 3D Printed Drugs Product
Table 32. GlaxoSmithKline Recent Developments
Table 33. Revolution Medicines Corporation Information
Table 34. Revolution Medicines Description and Major Businesses
Table 35. Revolution Medicines 3D Printed Drugs Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 36. Revolution Medicines 3D Printed Drugs Product
Table 37. Revolution Medicines Recent Developments
Table 38. FabRX Corporation Information
Table 39. FabRX Description and Major Businesses
Table 40. FabRX 3D Printed Drugs Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 41. FabRX 3D Printed Drugs Product
Table 42. FabRX Recent Developments
Table 43. 3D Printed Drugs Production Capacity (K Units) of Key Manufacturers in United States Market, 2019-2021 (K Units)
Table 44. United States 3D Printed Drugs Capacity Market Share of Key Manufacturers, 2019-2021
Table 45. 3D Printed Drugs Market Opportunities & Trends in United States Market
Table 46. 3D Printed Drugs Market Drivers in United States Market
Table 47. 3D Printed Drugs Market Restraints in United States Market
Table 48. 3D Printed Drugs Raw Materials
Table 49. 3D Printed Drugs Raw Materials Suppliers in United States Market
Table 50. Typical 3D Printed Drugs Downstream
Table 51. 3D Printed Drugs Downstream Clients in United States Market
Table 52. 3D Printed Drugs Distributors and Sales Agents in United States Market
List of Figures
Figure 1. 3D Printed Drugs Product Picture
Figure 2. 3D Printed Drugs Segment by Type
Figure 3. 3D Printed Drugs Segment by Application
Figure 4. United States 3D Printed Drugs Market Overview: 2020
Figure 5. United States 3D Printed Drugs Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. United States 3D Printed Drugs Revenue, 2016-2027 (US$, Mn)
Figure 7. 3D Printed Drugs Sales in United States Market: 2016-2027 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by 3D Printed Drugs Revenue in 2020
Figure 9. Spritam Product Picture
Figure 10. Others Product Picture
Figure 11. By Type - United States 3D Printed Drugs Sales Market Share, 2016-2027
Figure 12. By Type - United States 3D Printed Drugs Revenue Market Share, 2016-2027
Figure 13. By Type - United States 3D Printed Drugs Price (USD/Unit), 2016-2027
Figure 14. Children
Figure 15. Elderly
Figure 16. Others
Figure 17. By Application - United States 3D Printed Drugs Sales Market Share, 2016-2027
Figure 18. By Application - United States 3D Printed Drugs Revenue Market Share, 2016-2027
Figure 19. By Application - United States 3D Printed Drugs Price (USD/Unit), 2016-2027
Figure 20. Aprecia Pharmaceuticals 3D Printed Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 21. GlaxoSmithKline 3D Printed Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 22. Revolution Medicines 3D Printed Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 23. FabRX 3D Printed Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 24. United States 3D Printed Drugs Production Capacity (K Units), 2016-2027
Figure 25. 3D Printed Drugs Industry Value Chain
Figure 26. Marketing Channels

Keyplayers in United States 3D Printed Drugs Market Report & Forecast 2021-2027

Aprecia Pharmaceuticals
GlaxoSmithKline
Revolution Medicines
FabRX
market Reports market Reports